NeoGenomics, Inc. (NEO)

NeoGenomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	709.16	660.57	591.64	509.73	484.33	444.45
Revenue Growth (YoY)	10.10%	11.65%	16.07%	5.24%	8.97%	8.71%
Cost of Revenue	401.36	370.47	347.04	321.83	297.27	258.56
Gross Profit	307.81	290.1	244.6	187.9	187.06	185.89
Selling, General & Admin	356.08	330.64	312.83	310.68	283.94	191.66
Research & Development	35.87	31.16	27.31	30.33	21.87	8.23
Operating Expenses	391.94	361.8	340.14	341	305.81	199.89
Operating Income	-84.14	-71.7	-95.54	-153.11	-118.75	-13.99
Interest Expense	-4.78	-6.62	-6.91	-7.58	-8.22	-7.02
Interest & Investment Income	11.88	18.43	16.9	6.08	112.4	3.96
Other Non Operating Income (Expenses)	-0.22	-0.38	0.64	-0.21	-0.5	0.01
EBT Excluding Unusual Items	-77.26	-60.26	-84.9	-154.83	-15.08	-17.05
Merger & Restructuring Charges	-6.41	-6.66	-11.09	-4.52	-	-
Asset Writedown	-23.23	-	-	-	-	-
Legal Settlements	-1.4	-13.75	-1.11	-	-	-
Other Unusual Items	-2.2	-	-	-	-	2.99
Pretax Income	-113.99	-80.68	-97.1	-159.34	-15.08	-14.06
Income Tax Expense	-0.52	-1.95	-9.13	-15.09	-6.73	-18.23
Net Income	-113.47	-78.73	-87.97	-144.25	-8.35	4.17
Net Income to Common	-113.47	-78.73	-87.97	-144.25	-8.35	4.17
Net Income Growth	-	-	-	-	-	-47.89%
Shares Outstanding (Basic)	128	127	126	124	120	109
Shares Outstanding (Diluted)	128	127	126	124	120	112
Shares Change (YoY)	1.09%	0.92%	1.03%	3.55%	7.31%	7.89%
EPS (Basic)	-0.89	-0.62	-0.70	-1.16	-0.07	0.04
EPS (Diluted)	-0.89	-0.62	-0.70	-1.16	-0.07	0.04
EPS Growth	-	-	-	-	-	-51.78%
Free Cash Flow	-17.05	-34.04	-30.71	-96.88	-90.87	-27.64
Free Cash Flow Per Share	-0.13	-0.27	-0.24	-0.78	-0.76	-0.25
Gross Margin	43.40%	43.92%	41.34%	36.86%	38.62%	41.83%
Operating Margin	-11.86%	-10.85%	-16.15%	-30.04%	-24.52%	-3.15%
Profit Margin	-16.00%	-11.92%	-14.87%	-28.30%	-1.72%	0.94%
Free Cash Flow Margin	-2.40%	-5.15%	-5.19%	-19.01%	-18.76%	-6.22%
EBITDA	-14.52	0.85	-22.95	-83.68	-65.4	21.73
EBITDA Margin	-2.05%	0.13%	-3.88%	-16.42%	-13.50%	4.89%
D&A For EBITDA	69.62	72.55	72.58	69.43	53.35	35.72
EBIT	-84.14	-71.7	-95.54	-153.11	-118.75	-13.99
EBIT Margin	-11.86%	-10.85%	-16.15%	-30.04%	-24.52%	-3.15%
Revenue as Reported	-	-	-	-	484.33	444.45

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q